Spire Healthcare Group (LON:SPI) Shares Up 14.1% - Time to Buy?

Key Points

• Spire Healthcare Group's shares surged 14.1% to a trading price of GBX 256.50, significantly above its previous close of GBX 216.50.
• Analysts have a consensus rating of "Buy" for the stock, with a target price averaging GBX 294.33.
• In its latest quarterly earnings report, Spire Healthcare Group posted GBX 4.10 earnings per share, with a net margin of 1.96%.

Shares of Spire Healthcare Group plc (LON:SPI - Get Free Report) shot up 14.1% during trading on Saturday . The stock traded as high as GBX 256.50 ($3.47) and last traded at GBX 247 ($3.34). 9,747,062 shares were traded during trading, an increase of 563% from the average session volume of 1,469,073 shares. The stock had previously closed at GBX 216.50 ($2.93).

Analyst Ratings Changes

Several research analysts have issued reports on the stock. JPMorgan Chase & Co. decreased their target price on shares of Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating for the company in a report on Tuesday, August 5th. Berenberg Bank restated a "buy" rating and issued a GBX 280 price target on shares of Spire Healthcare Group in a research note on Thursday, July 31st. Three research analysts have rated the stock with a Buy rating, According to MarketBeat, Spire Healthcare Group presently has a consensus rating of "Buy" and an average target price of GBX 294.33.

Spire Healthcare Group Trading Down 4.7%

The stock has a fifty day simple moving average of GBX 218.99 and a 200 day simple moving average of GBX 203.96. The firm has a market capitalization of £947.58 million, a P/E ratio of 5,119.57, a PEG ratio of 1.06 and a beta of 0.96. The company has a quick ratio of 0.74, a current ratio of 0.70 and a debt-to-equity ratio of 62.25.

Spire Healthcare Group (LON:SPI - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The company reported GBX 4.10 earnings per share for the quarter. Spire Healthcare Group had a return on equity of 3.82% and a net margin of 1.96%. As a group, research analysts forecast that Spire Healthcare Group plc will post 15.6634747 EPS for the current year.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.